Table 3 Demographic and clinical characteristics of the study participants at baseline
Characteristic | Intervention group (n = 17) | Control group (n = 18) |
|---|---|---|
Age, years | 78.6 ± 7.5 | 83.1 ± 7.4 |
Sex, female, n (%) | 13 (76%) | 13 (72%) |
Mini-Mental State Examination, 0–30 points | 25.7 ± 3.0 | 26.4 ± 2.8 |
Barthel Index, 0–100 points | 62.9 ± 13.9 | 58.3 ± 17.2 |
Comorbidities, median (IQR) | 2 (0–4) | 2.5 (2–3.25) |
Multimorbidity (≥2 comorbidities), n (%) | 10 (59%) | 15 (83%) |
Time admission to baseline, days | 2.4 ± 1.4 | 2.3 ± 1.3 |
Time baseline to follow-up, days | 12.4 ± 2.6a | 12.5 ± 2.1b |
Time follow-up to discharge, days | 3.7 ± 2.8 | 3.8 ± 1.7 |
Primary diagnosis according to ICD-10 | ||
IV Endocrine, nutritional and metabolic diseases, n (%) | 0 | 2 (11%) |
VI Diseases of the nervous system, n (%) | 3 (18%) | 1 (6%) |
IX Circulatory, n (%) | 3 (18%) | 3 (17%) |
X Respiratory, n (%) | 0 | 3 (17%) |
XI Digestive system, n (%) | 1 (6%) | 0 |
XIII Musculoskeletal, n (%) | 7 (41%) | 5 (28%) |
XVIII Symptoms, signs and abnormal clinical and laboratory findings, n (%) | 2 (12%) | 4 (22%) |
XIX Injury, poisoning and certain other consequences of external causes, n (%) | 1 (6%) | 0 |
Functional Ambulation Category, median (IQR) | 4 (3–4) | 4 (3–4) |
3, n (%) | 5 (29%) | 7 (39%) |
4, n (%) | 12 (71%) | 10 (56%) |
5, n (%) | 0 | 1 (6%) |
Walking aid | ||
None, n (%) | 2 (12%) | 4 (22%) |
Wheeled-walker/rollator, n (%) | 14 (82%) | 13 (72%) |
Cane/single crutch, n (%) | 1 (6%) | 1 (6%) |